Proposed Data Collection Submitted for Public Comment and Recommendations, 14266-14267 [2022-05300]
Download as PDF
<![CDATA[
14266
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22DF; Docket No. CDC–2022–
0034]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to take this opportunity to
comment on a proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Assessing the
Availability of COVID–19 Testing at
U.S. Airports. This project is designed
to collect information on the availability
of testing for COVID–19 to travelers at
U.S. airports.
DATES: Written comments must be
received on or before May 13, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0034, by either of the following
methods:
• Federal eRulemaking Portal:
regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
SUMMARY:
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeff Zirger,
Information Collection Review Office,
jspears on DSK121TN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
(1) Evaluate whether the proposed
collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information
shall have practical utility;
(2) Evaluate the accuracy of the agency’s
estimate of the burden of the proposed
collection of information;
(3) Enhance the quality, utility, and clarity
of the information to be collected;
(4) Minimize the burden of the collection
of information on respondents, including
through the use of automated collection
techniques or other forms of information
technology (e.g., permitting electronic
submissions of responses); and
(5) Assess information collection costs.
Proposed Project
Information Collection for Assessing
the Availability of COVID–19 Testing at
U.S. Airports—New—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Quarantine and Border Health Services
Branch (QBHSB) requests approval for a
new information collection request.
This project pertains to collecting
information on the availability of testing
for COVID–19 to travelers at U.S.
airports.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
The respondents are airport directors
or their designees at 522 airports in the
continental United States, the District of
Columbia, or any territory or possession
of the United States. These airports
serve passenger-carrying operations
conducted on certified air carriers. This
project will initially pilot with a sample
of 100 airports and subsequently expand
to include the remaining 422 Schedule
A passenger-carrying U.S. or territorial
airports following the initial rollout, for
a total of 522 airports. The 100 sampled
airports were selected based on the
following criteria: (1) Having more than
1,000 international arrivals in 2019, or
(2) having a CDC quarantine station, or
if not meeting one of the above criteria,
and (3) ranking among the top in
domestic arrival passenger volume for
2019 (U.S. Bureau of Transportation).
These airports represent 89% of
domestic and international travel for
2019.
To achieve DGMQ’s mission, QBHSB
works with domestic and international
programs to protect the U.S. public by
preventing importation of infectious
disease through travel. Some U.S.
airports have facilitated COVID–19
testing locations for departing or
arriving domestic and international
travelers (passengers and crew). QBHSB
seeks to regularly obtain comprehensive
and updated information on COVID–19
testing activities occurring at U.S.
airports, which allows CDC to monitor
trends in testing offered at airports. The
information collected in this project will
be used primarily to ascertain the scope
of testing activities and to eventually
provide information to the traveling
public on testing availability at U.S.
airports. Existing surveillance systems
do not collect this type of information,
thereby preventing CDC from
monitoring airport testing trends and
improving program effectiveness,
particularly during an emergency
response.
Currently, CDC is requesting this data
be sent by airport directors or their
designees at least twice per year, with
monthly reminder emails being sent to
encourage response. The consequences
of reducing this frequency would be the
inability to obtain comprehensive and
updated information in a timely manner
which could affect program
improvement.
CDC requests OMB approval for an
estimated 33,060 annual burden hours.
There is no cost to the respondents
other than their time.
E:\FR\FM\14MRN1.SGM
14MRN1
14267
Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Airport directors or managers (All airports).
COVID–19 Airport Testing Planner
web form.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–05300 Filed 3–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1105]
Agency Forms Undergoing Paperwork
Reduction Act Review
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘One Health
Harmful Algal Bloom System
(OHHABS)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on November
16, 2021 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
VerDate Sep<11>2014
17:51 Mar 11, 2022
Jkt 256001
522
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
One Health Harmful Algal Bloom
System (OHHABS) (OMB Control No.
0920–1105, Exp. 3/31/2022)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID) requests a three-year
Revision for the One Health Harmful
Algal Bloom System (OHHABS) for
harmful algal bloom (HAB) and HABassociated illness surveillance.
HABs are the rapid growth of algae or
cyanobacteria (also called blue-green
algae) that can cause harm to people,
animals, or the local ecology. Toxins
from HABs include some of the most
potent natural chemicals; these toxins
can contaminate surface water used for
recreation and drinking, as well as food
sources. HABs pose a threat to both
humans and animals. Human and
animal illnesses from exposures to
HABs in fresh and marine waters have
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
20
Average
burden per
response
(in hours)
190/60
Total
burden
(in hours)
33,060
been documented throughout the
United States. Animal illness may be an
indicator of bloom toxicity; thus, it is
necessary to provide a One Health
approach for reporting HAB-associated
illnesses and events.
HABs are an emerging public health
concern. For 2016—2019, 22 states
adopted use of the OHHABS and
entered 669 reports, including
information about 452 human illnesses
and at least 481 animal illnesses
associated with HAB events. Of the 669
HAB event reports, 84% were associated
with freshwater, resulting in 428 (95%)
of human illnesses. In these freshwater
settings, the most common signs and
symptoms reported include generalized
(e.g., headache, fever, fatigue),
gastrointestinal, and dermatologic.
Known adverse health effects from
HABs in marine waters include
respiratory illness and seafood
poisoning. In 2007, 15 persons were
affected with respiratory illness from
exposures to brevetoxins, an algal toxin,
during a Florida red tide. From 2007–
2011, HAB-associated foodborne
exposures were identified for 273 case
reports of human illness through a
separate five-year data collection effort
with a subset of states. Of these reports,
248 reported ciguatera fish poisoning
(CFP) or poisoning by other toxins in
seafood, including saxitoxin and
brevetoxin. A review of national
outbreak data reported to CDC for the
time period 1998–2015, identified
outbreaks CFP as the second most
common cause of fish-associated
foodborne disease outbreaks in the
United States, among those outbreaks
with a confirmed etiology. For this time
period, 227 CFP outbreaks resulted in
894 illnesses and 96 hospitalizations.
For 2016–2018, an additional 47
outbreak investigations implicated CFP,
resulting in 147 illnesses and 12
hospitalizations.
Domestic animal, livestock, and
wildlife HAB-associated illnesses have
also been documented in the United
States. Between 2016 and 2019, 79 cases
of domestic pet illness were reported to
OHHABS, with 39% (n=31) resulting in
death. During the same time period,
there were at least 53 livestock illnesses
and 349 wildlife illnesses reported. The
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14266-14267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05300]
[[Page 14266]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22DF; Docket No. CDC-2022-0034]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies to take this opportunity to comment on a proposed and/
or continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Assessing the Availability of
COVID-19 Testing at U.S. Airports. This project is designed to collect
information on the availability of testing for COVID-19 to travelers at
U.S. airports.
DATES: Written comments must be received on or before May 13, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0034, by either of the following methods:
Federal eRulemaking Portal: regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeff Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
(1) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information shall have practical utility;
(2) Evaluate the accuracy of the agency's estimate of the burden
of the proposed collection of information;
(3) Enhance the quality, utility, and clarity of the information
to be collected;
(4) Minimize the burden of the collection of information on
respondents, including through the use of automated collection
techniques or other forms of information technology (e.g.,
permitting electronic submissions of responses); and
(5) Assess information collection costs.
Proposed Project
Information Collection for Assessing the Availability of COVID-19
Testing at U.S. Airports--New--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ), Quarantine and Border Health
Services Branch (QBHSB) requests approval for a new information
collection request. This project pertains to collecting information on
the availability of testing for COVID-19 to travelers at U.S. airports.
The respondents are airport directors or their designees at 522
airports in the continental United States, the District of Columbia, or
any territory or possession of the United States. These airports serve
passenger-carrying operations conducted on certified air carriers. This
project will initially pilot with a sample of 100 airports and
subsequently expand to include the remaining 422 Schedule A passenger-
carrying U.S. or territorial airports following the initial rollout,
for a total of 522 airports. The 100 sampled airports were selected
based on the following criteria: (1) Having more than 1,000
international arrivals in 2019, or (2) having a CDC quarantine station,
or if not meeting one of the above criteria, and (3) ranking among the
top in domestic arrival passenger volume for 2019 (U.S. Bureau of
Transportation). These airports represent 89% of domestic and
international travel for 2019.
To achieve DGMQ's mission, QBHSB works with domestic and
international programs to protect the U.S. public by preventing
importation of infectious disease through travel. Some U.S. airports
have facilitated COVID-19 testing locations for departing or arriving
domestic and international travelers (passengers and crew). QBHSB seeks
to regularly obtain comprehensive and updated information on COVID-19
testing activities occurring at U.S. airports, which allows CDC to
monitor trends in testing offered at airports. The information
collected in this project will be used primarily to ascertain the scope
of testing activities and to eventually provide information to the
traveling public on testing availability at U.S. airports. Existing
surveillance systems do not collect this type of information, thereby
preventing CDC from monitoring airport testing trends and improving
program effectiveness, particularly during an emergency response.
Currently, CDC is requesting this data be sent by airport directors
or their designees at least twice per year, with monthly reminder
emails being sent to encourage response. The consequences of reducing
this frequency would be the inability to obtain comprehensive and
updated information in a timely manner which could affect program
improvement.
CDC requests OMB approval for an estimated 33,060 annual burden
hours. There is no cost to the respondents other than their time.
[[Page 14267]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Airport directors or managers COVID-19 Airport 522 20 190/60 33,060
(All airports). Testing Planner
web form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-05300 Filed 3-11-22; 8:45 am]
BILLING CODE 4163-18-P
